Advertisement

CNS Drugs

, Volume 26, Issue 9, pp 725–732 | Cite as

Pharmacotherapy for Parents with Attention-Deficit Hyperactivity Disorder (ADHD)

Impact on Maternal ADHD and Parenting
  • Andrea Chronis-TuscanoEmail author
  • Mark A. Stein
Leading Article

Abstract

Given the high heritability of the disorder, attention-deficit hyperactivity disorder (ADHD) is common among parents of children with ADHD. Parental ADHD is associated with maladaptive parenting, negative parent-child interaction patterns and a diminished response to behavioural parent training. We describe our previous research demonstrating that stimulant medications for mothers with ADHD are associated with reductions in maternal ADHD symptoms. Although limited beneficial effects on self-reported parenting were also found in our study, the impact of ADHD medications on functional outcomes related to parenting and family interactions may not be sufficient for many families. Many questions remain with regard to how best to treat multiplex ADHD families in which a parent and child have ADHD. In particular, future studies are needed: (1) to evaluate how best to sequence pharmacotherapy, psychosocial treatment for adult ADHD and behavioural parenting interventions; (2) to determine the best approach to maintaining treatment effects over the long term for both parents and children; and (3) to identify individual predictors of treatment response.

Keywords

Methylphenidate ADHD Symptom Atomoxetine Stimulant Medication Adult ADHD 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The authors’ research described in this article was funded by the National Institute of Mental Health (R03MH070666-1) and an investigator-initiated study from McNeil Pediatrics, both awarded to Dr Chronis-Tuscano. Dr Stein currently has research support from Shire. No funding was received to prepare this article.

References

  1. 1.
    Barkley RA, Fischer M, Smallish L, et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol 2002; 111: 279–89PubMedCrossRefGoogle Scholar
  2. 2.
    Weiss G, Hechtman LT. Hyperactive children grown up: ADHD in children, adolescents and adults. 2nd ed. New York (NY): Guildford Press, 1993Google Scholar
  3. 3.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders: text revision. 4th ed. Washington, DC: American Psychiatric Association, 2000Google Scholar
  4. 4.
    Faraone SV, Biederman J, Feighner JA, et al. Assessing symptoms of attention deficit hyperactivity disorder in children and adults: which is more valid? J Consult Clin Psychol 2000; 68: 830–42PubMedCrossRefGoogle Scholar
  5. 5.
    McGough JJ, Barkley RA. Diagnostic controversies in adult attention deficit hyperactivity disorder. Am J Psychiatry 2004; 161: 1948–56PubMedCrossRefGoogle Scholar
  6. 6.
    Stein MA. Impairment associated with adult ADHD. CNS Spectr 2008; 13(8 Suppl. 12): 9–11PubMedGoogle Scholar
  7. 7.
    Faraone SV, Biederman J, Spencer T, et al. Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 2000; 48: 9–20PubMedCrossRefGoogle Scholar
  8. 8.
    Eakin L, Minde K, Hechtman L, et al. The marital and family functioning of adults with ADHD and their spouses. J Atten Disord 2004; 8: 1–10PubMedCrossRefGoogle Scholar
  9. 9.
    Weiss M, Hechtman L, Weiss G. ADHD in parents. J Am Acad Child Adolesc Psychiatry 2000; 39: 1059–61PubMedCrossRefGoogle Scholar
  10. 10.
    Cantwell DP. Psychiatric illness in the families of hyperactive children. Arch Gen Psychiat 1972; 27: 414–7PubMedCrossRefGoogle Scholar
  11. 11.
    Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313–23PubMedCrossRefGoogle Scholar
  12. 12.
    Biederman J, Wilens TE, Mick E, et al. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152: 1652–8PubMedGoogle Scholar
  13. 13.
    Chronis AM, Lahey BB, Pelham WE, et al. Psychotherapy and substance abuse in parents of young children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2003; 42(12): 1424–32PubMedCrossRefGoogle Scholar
  14. 14.
    Epstein JN, Conners CK, Erhardt DL, et al. Familial aggregation of ADHD characteristics. J Abnorm Child Psychol 2000; 28(6): 585–94PubMedCrossRefGoogle Scholar
  15. 15.
    Mannuzza S, Klein RG. Long-term prognosis in attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin? Am 2000; 9(3): 711–26Google Scholar
  16. 16.
    Chronis AM, Lahey BB, Pelham Jr WE, et al. Maternal depression and early positive parenting predict future conduct problems in young children with attention-deficit/hyperactivity disorder. Dev Psychol 2007; 43(1): 70–82PubMedCrossRefGoogle Scholar
  17. 17.
    Johnson C, Mash EJ. Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clin Child Fam Psychol Rev 2001; 4(3): 183–207CrossRefGoogle Scholar
  18. 18.
    Biederman J, Faraone SV, Monuteaux MC. Differential effect of environmental adversity by gender: Rutter’s index of adversity in a group of boys and girls with and without ADHD. Am J Psychiatry 2002; 159: 1556–62PubMedCrossRefGoogle Scholar
  19. 19.
    Arnold EH, O’Leary SG, Edwards GH. Father involvement and self-report parenting of children with attention deficit-hyperactivity disorder. J Consult Clin Psychol 1997; 65(2): 337–42PubMedCrossRefGoogle Scholar
  20. 20.
    Barkley RA, Murphy KR, Fischer M. ADHD in adults: what the science says. New York (NY): The Guilford Press, 2008Google Scholar
  21. 21.
    Biederman J, Faraone SV, Spencer TJ, et al. Functional impairments in adults with self-reports of diagnosed ADHD: a controlled study of 1001 adults in the community. J Clin Psychiatry 2006; 67: 524–40PubMedCrossRefGoogle Scholar
  22. 22.
    Fabiano GA. Father participation in behavioral parent training for ADHD: review and recommendations for increasing inclusion and engagement. J Fam Psychol 2007; 21: 683–93PubMedCrossRefGoogle Scholar
  23. 23.
    Murray C, Johnston C. Parenting in mothers with and without attention deficit/hyperactivity disorder. J Abnorm Psychol 2006; 115: 52–61PubMedCrossRefGoogle Scholar
  24. 24.
    Chronis-Tuscano AM, Raggi V, Clarke TL, et al. Associations between maternal attention-deficit/hyperactivity disorder symptoms and parenting. J Abnorm Child Psychol 2008; 36(8): 1237–50PubMedCrossRefGoogle Scholar
  25. 25.
    Pelham WE, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 1998; 27: 190–205PubMedCrossRefGoogle Scholar
  26. 26.
    Chronis-Tuscano A, O’Brien KA, Johnston C, et al. The relation between maternal ADHD symptoms and improvement in child behavior following brief behavioral parent training is mediated by change in negative parenting. J Abnorm Child Psychol 2011; 39: 1047–57PubMedCrossRefGoogle Scholar
  27. 27.
    Evans S, Vallano G, Pelham W. Treatment of parenting behavior with a psychostimulant: a case study of an adult with attention-deficit hyperactivity disorder. JCAP 1994; 4: 63–9Google Scholar
  28. 28.
    Sonuga-Barke E, Daley D, Thompson M. Does maternal ADHD reduce the effectiveness of parent training for preschool children’s ADHD?. J Am Acad Child Adolesc Psychiatry 2002; 41: 696–702PubMedCrossRefGoogle Scholar
  29. 29.
    Wells KC, Chi TC, Hinshaw SP, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder. J Consult Clin Psychol 2006; 74(4): 649–57PubMedCrossRefGoogle Scholar
  30. 30.
    Owens EB, Hinshaw SP, Kraemer HC. Which treatment for whom for ADHD?. Moderators of treatment response in the MTA. J Consult Clin Psychol 2003; 71: 540–52PubMedCrossRefGoogle Scholar
  31. 31.
    Jensen PS, Arnold LE, Swanson JM, et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry 2007; 46(8): 989–1002PubMedCrossRefGoogle Scholar
  32. 32.
    Wilens TE. Pharmacotherapy of ADHD in adults. CNS Spectr 2008; 13(5 Suppl. 8): 11–30PubMedGoogle Scholar
  33. 33.
    Adler LA, Spencer T, Brown TE. Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol 2009; 29(1): 44–50PubMedCrossRefGoogle Scholar
  34. 34.
    Biederman J, Mick E, Surman C, et al. A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2006; 59(9): 829–35PubMedCrossRefGoogle Scholar
  35. 35.
    Wilens TE, Morrison NR, Prince J. An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults. Expert Rev Neurother 2011; 11(10): 1443–65PubMedCrossRefGoogle Scholar
  36. 36.
    Gordon M, Antshel K, Faraone S, et al. Symptoms versus impairment: the case for respecting DSM-IV’s Criterion D. J Atten Disord 2006; 9(3): 465–75PubMedCrossRefGoogle Scholar
  37. 37.
    Medori R, Ramos-Quiroga AR, Casas M, et al. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 2008; 63: 981–9PubMedCrossRefGoogle Scholar
  38. 38.
    Leon AC, Olfson M, Portera L, et al. Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. Int J Psychiat Med 1997; 27: 93–105CrossRefGoogle Scholar
  39. 39.
    Wender PH, Reimherr FW, Marchant BK, et al. A one year trial of methylphenidate in the treatment of ADHD. J Atten Disord 2011; 15(1): 36–45PubMedCrossRefGoogle Scholar
  40. 40.
    Adler LA, Spencer TJ, Williams DW, et al. Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study. J Atten Disord 2008; 12: 248–53PubMedCrossRefGoogle Scholar
  41. 41.
    Barkley RA, Cunningham C. The effects of methylphenidate on the mother-child interactions of hyperactive children. Arch Gen Psychiatry 1979; 36(2): 201–8PubMedCrossRefGoogle Scholar
  42. 42.
    Barkley RA, Karlsson J, Pollard S, et al. Developmental changes in the mother-child interactions of hyperactive boys: effects of two dose levels of Ritalin. J Child Psychol Psychiatry 1985; 26(5): 705–16PubMedCrossRefGoogle Scholar
  43. 43.
    Biederman J, Milberger S, Faraone SV, et al. Family-environment risk factors for attention-deficit hyperactivity disorder: a test of Rutter’s indicators of adversity. Arch Gen Psychiatry 1995; 52(6): 464–70PubMedCrossRefGoogle Scholar
  44. 44.
    Hinshaw SP, Owens EB, Wells KC, et al. Family processes and treatment outcome in the MTA: negative/ineffective parenting practices in relation to multimodal treatment. J Abnorm Child Psychol 2000; 28(6): 555–68PubMedCrossRefGoogle Scholar
  45. 45.
    Biederman J, Petty CR, Clarke A, et al. Predictors of persistent ADHD: an 11-year follow-up study. J Psychiatr Res 2011; 45(2): 150–5PubMedCrossRefGoogle Scholar
  46. 46.
    Chronis-Tuscano AM, Seymour KE, Stein MA, et al. Methylphenidate for mothers with ADHD: preliminary effects on ADHD symptoms and parenting. J Am Acad Child Adoles Psychiatry 2008; 69: 1938–47Google Scholar
  47. 47.
    Shelton KK, Frick PJ, Wooton J. Assessment of parenting practices in families of elementary school-age children. J Clin Child Psychol 1996; 25(3): 317–29CrossRefGoogle Scholar
  48. 48.
    Chronis-Tuscano A, Rooney M, Seymour KE, et al. Effects of maternal stimulant medication on observed parenting in mother-child dyads with ADHD. J Clin Child Adolesc Psychol 2012; 39: 581–7Google Scholar
  49. 49.
    Solanto MV, Marks DJ, Wasserstein J, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010; 167(8): 958–68PubMedCrossRefGoogle Scholar
  50. 50.
    Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs. relaxation with education support for medication-treated adults with ADHD and persistent symptoms. JAMA 2010; 308(8): 875–80CrossRefGoogle Scholar
  51. 51.
    Knouse LE, Safren SA. Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. Psychiatr Clin North Am 2010; 33(3): 497–509PubMedCrossRefGoogle Scholar
  52. 52.
    Safren SA, Otto MW, Sprich S, et al. Cognitive-behavioral therapy for adult ADHD in medication-treated adults with continued symptoms. Behav Res Ther 2005; 43: 831–42PubMedCrossRefGoogle Scholar
  53. 53.
    Weissman MM, Pilowsky DJ, Wickramaratne PJ, et al. Remissions in maternal depression and child psychopathology: a START*D-Child report. JAMA 2006; 295(12): 1389–98PubMedCrossRefGoogle Scholar
  54. 54.
    Lahey BB, Rathouz PJ, Chronis-Tuscano A, et al. Interactions between early parenting and a polymorphism of the child’s dopamine transporter gene in predicting future child conduct disorder symptoms. J Abnorm Psychol 2011; 120(1): 33–45PubMedCrossRefGoogle Scholar
  55. 55.
    Molina BSG, Hinshaw SP, Swanson JM, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 2009; 48(5): 484–500PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2012

Authors and Affiliations

  1. 1.Department of PsychologyUniversity of MarylandCollege ParkUSA
  2. 2.Departments of Psychiatry and PediatricsUniversity of Illinois at ChicagoChicagoUSA

Personalised recommendations